C4A and C9 have been identified in the synovial fluid of patients with ankylosing spondylitis, a rheumatic autoimmune disease, so complement activation is not inevitably tied to pathogen-associated infection but can also be a sign of aseptic inflammation, limiting its diagnostic value in this matter even further [22]. This evidence concerns the gene C9 and ankylosing spondylitis.